Drug intelligence / Profile preview

ciplukan extract

Development stage
Preclinical
Lead developer
Universitas Padjadjaran
Administration
Oral, Topical
01

Overview

Ciplukan extract is derived from the plant *Physalis angulata Linn.*, which is used in traditional Indonesian medicine. [5, 7] It is being investigated for its anti-inflammatory, antiproliferative, and immunosuppressive properties. [9] The extract contains multiple active compounds, including physalins (such as B, D, F, and G), withanolides, flavonoids (like quercetin), and other seco-steroids. [2, 3, 7] Preclinical studies in mouse models have demonstrated that ciplukan extract can improve psoriasis manifestations by inhibiting inflammatory pathways, including the TGF-β1/NF-κB pathway and reducing the expression of cytokines like IL-17 and IFN-γ. [7, 11] A topical formulation is being evaluated in a clinical trial (NCT06887322) as a potential adjuvant therapy for psoriasis vulgaris. [6]

Other names
Physalis angulata extractPhysalis angulata L. extract
02

Targets

AMY (Pancreatic alpha-amylase)NF-κBPI3K (Phosphoinositide-3-kinase regulatory subunit 6)

Beyond the preview

Go deeper on ciplukan extract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ciplukan extract.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call